Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 704 (USA) (Dr. Tanaka)
· consented 2013-10-12
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild FLATULENCE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-27 (study day 16.0); relationship: NONE
mild
assessed
2026-08-18
Mild FLATULENCE — outcome: RECOVERED/RESOLVED; onset 2013-10-27 (study day 16.0); relationship: NONE
mild
assessed
2026-08-18
Mild POLLAKIURIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-27 (study day 16.0); relationship: NONE
mild
assessed
2026-08-18
Mild POLLAKIURIA — outcome: RECOVERED/RESOLVED; onset 2013-10-27 (study day 16.0); relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.